Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI Vaccines

Clinical trial NCT03274102 · COMPLETED

Trial details

NCT number: NCT03274102
Sponsor: Sinovac Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hand, Foot and Mouth Disease

Start date: 2017-04-22
Primary completion: 2017-11-01
Enrollment: 780

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.